Mutational analysis of PTEN/PIK3CA/AKT pathway in oral squamous cell carcinoma.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Oral Oncology

• Publication date

  2011-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.oraloncology.2011.07.013PMID 21824802
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The frequent co-expression of the oncogenes PIK3CA and PAK1 in oral carcinomas.

  2011cited by this paper
• Cancer Statistics, 2010

  2010cited by this paper
• Mutational analyses of the BRAF, KRAS, and PIK3CA genes in oral squamous cell carcinoma.

  2010cited by this paper
• AKT1 pleckstrin homology domain E17K activating mutation in endometrial carcinoma.

  2010cited by this paper
• Absence of hotspot mutations in exons 9 and 20 of the PIK3CA gene in human oral squamous cell carcinoma in the Greek population.

  2010cited by this paper
• AKT1 E17 K pleckstrin homology domain mutation in urothelial carcinoma.

  2009cited by this paper
• Activating E17K mutation in the gene encoding the protein kinase AKT in a subset of squamous cell carcinoma of the lung

  2008cited by this paper
• Hypermethylation of CpG island loci of multiple tumor suppressor genes in retinoblastoma.

  2008cited by this paper
• Mutational analysis of oncogenic AKT E17K mutation in common solid cancers and acute leukaemias

  2008cited by this paper
• RAS: Target for Cancer Therapy

  2008cited by this paper
• PI3K/AKT pathway activation in acute myeloid leukaemias is not associated with AKT1 pleckstrin homology domain mutation

  2008cited by this paper
• Activating E17K mutation in the gene encoding the protein kinase AKT1 in a subset of squamous cell carcinoma of the lung.

  2008cited by this paper
• The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications.

  2008cited by this paper
• Recurrent gross mutations of the PTEN tumor suppressor gene in breast cancers with deficient DSB repair

  2008cited by this paper
• Chronic lymphocytic leukaemia and acute myeloid leukaemia are not associated with AKT1 pleckstrin homology domain (E17K) mutations

  2008cited by this paper
• Analysis of PIK3CA and Akt/protein kinase B in head and neck squamous cell carcinoma.

  2007cited by this paper
• PTEN, more than the AKT pathway.

  2007cited by this paper
• A transforming mutation in the pleckstrin homology domain of AKT1 in cancer

  2007cited by this paper
• KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer.

  2006cited by this paper
• PIK3CA mutation is an oncogenic aberration at advanced stages of oral squamous cell carcinoma

  2006cited by this paper
• PIK3CA Mutations in Head and Neck Squamous Cell Carcinoma

  2006cited by this paper
• Global Cancer Statistics, 2002

  2005cited by this paper
• Prognostic value of activated Akt expression in oral squamous cell carcinoma

  2005cited by this paper
• Akt activation correlates with adverse outcome in tongue cancer

  2005cited by this paper
• High Frequency of Mutations of the PIK3CA Gene in Human Cancers

  2004cited by this paper
• Persistent Activation of the Akt Pathway in Head and Neck Squamous Cell Carcinoma

  2004cited by this paper
• RAS oncogenes: the first 30 years

  2003cited by this paper
• Rapid Akt activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cells.

  2003cited by this paper
• PTEN: from pathology to biology.

  2003cited by this paper
• Genomic gain of PIK3CA and increased expression of p110alpha are associated with progression of dysplasia into invasive squamous cell carcinoma

  2002cited by this paper
• Amplification of wild-type K-ras promotes growth of head and neck squamous cell carcinoma.

  2002cited by this paper
• The phosphatidylinositol 3-Kinase–AKT pathway in human cancer

  2002cited by this paper
• Inactivation of the PTEN gene by mutation, exonic deletion, and loss of transcript in human oral squamous cell carcinomas.

  2002cited by this paper
• Discovery of a novel Raf kinase inhibitor.

  2001cited by this paper
• Cellular function of phosphoinositide 3-kinases: implications for development, homeostasis, and cancer.

  2001cited by this paper
• AKT plays a central role in tumorigenesis

  2001cited by this paper
• Cellular function of phosphoinositide 3-kinases: Implications for development, immunity, homeostasis, and cancer

  2001cited by this paper
• ras gene mutations in oral cancer in eastern India.

  2000cited by this paper
• PIK3CA is implicated as an oncogene in ovarian cancer

  1999cited by this paper
• Increasing complexity of Ras signaling

  1998cited by this paper
• Activated ras genes occur in human actinic keratoses, premalignant precursors to squamous cell carcinomas.

  1995cited by this paper
• Ras mutations in united kingdom examples of oral malignancies are infrequent

  1991cited by this paper

• Molecular Mechanisms in the Carcinogenesis of Oral Squamous Cell Carcinoma: A Literature Review

  2025cites this paper
• Potential anticancer properties of Tetraselmis suecica extract against oral and colorectal cancer cells

  2025cites this paper
• C-Phycocyanin induces apoptosis in oral squamous cell carcinoma KB cells via modulation of key molecular pathways

  2025cites this paper
• Multiple Mutations—A Genetic Marker for Extracapsular Spread in Human Papillomavirus/p16‐Positive Oropharyngeal Carcinoma

  2025cites this paper
• Omics Sciences in Dentistry: A Narrative Review on Diagnostic and Therapeutic Applications for Prevalent Oral Diseases

  2025cites this paper
• Current and Emerging Protein Biomarkers for the Diagnosis and Prognosis of Head and Neck Cancer

  2025cites this paper
• Dysregulated PI3K/AKT signaling in oral squamous cell carcinoma: The tumor microenvironment and epigenetic modifiers as key drivers

  2025cites this paper
• Protein interaction network drive more group integrated analytic larynx hub protein markers: LYVE1/FBLN5/INMT/DCN/ZFY/RSPO3 protein macromolecule collaborative diagnosis of a new era.

  2025cites this paper
• Antiapoptotic PON2 expression and its clinical implications in locally advanced oral squamous cell carcinoma

  2024cites this paper
• Genetics Affecting the Prognosis of Dental Treatments.

  2024cites this paper
• Epigenetic methylation changes: implication as biomarkers in oral and maxillofacial area cancers

  2023influential citation
• Review of Disease-Specific microRNAs by Strategically Bridging Genetics and Epigenetics in Oral Squamous Cell Carcinoma

  2023cites this paper
• Targeted therapy for head and neck cancer: signaling pathways and clinical studies

  2023cites this paper
• Involvement of the p53‐p16/RB pathway control mechanism in early‐stage carcinogenesis in head and neck squamous cell carcinoma

  2022cites this paper
• KRAS Protein Expression in Oral Squamous Cell Carcinoma: A Potential Marker for Progression and Prognosis

  2022cites this paper
• Impact of tobacco smoking on oral cancer genetics—A next‐generation sequencing perspective

  2022cites this paper
• Molecular Crosstalk between the Immunological Mechanism of the Tumor Microenvironment and Epithelial–Mesenchymal Transition in Oral Cancer

  2022cites this paper
• Topology-based protein–protein interaction analysis of oral cancer proteins

  2022cites this paper
• Stromal cells in the tumor microenvironment promote the progression of oral squamous cell carcinoma

  2021cites this paper
• Worldwide Prevalence of PI3K-AKT-mTOR Pathway Mutations in Head and Neck Cancer: A Systematic Review and Meta-Analysis.

  2021cites this paper
• The PI3K/Akt/mTORC signaling axis in head and neck squamous cell carcinoma: Possibilities for therapeutic interventions either as single agents or in combination with conventional therapies

  2021cites this paper
• Apoptosis and genes involved in oral cancer - a comprehensive review

  2020cites this paper
• Prognostic value of the PIK3CA, AKT, and PTEN mutations in oral squamous cell carcinoma: literature review

  2020cites this paper
• Genetic alterations and clinical dimensions of oral cancer: a review

  2020cites this paper
• Signaling pathways promoting epithelial mesenchymal transition in oral submucous fibrosis and oral squamous cell carcinoma

  2020cites this paper
• Preclinical characterization of CPL302-253, a selective inhibitor of PI3Kδ, as the candidate for the inhalatory treatment and prevention of Asthma

  2020cites this paper
• PIK3CA and p53 Mutations Promote 4NQO-Initated Head and Neck Tumor Progression and Metastasis in Mice

  2020cites this paper
• β-Caryophyllene promotes oxidative stress and apoptosis in KB cells through activation of mitochondrial-mediated pathway – An in-vitro and in-silico study

  2019cites this paper
• Oral Cancer Detection

  2019influential citation
• Activation of BDNF/TrkB/Akt pathway is associated with aggressiveness and unfavorable survival in oral squamous cell carcinoma.

  2019cites this paper
• Osthole induces cell cycle arrest and apoptosis in head and neck squamous cell carcinoma by suppressing the PI3K/AKT signaling pathway.

  2019cites this paper
• Genetics and Molecular Mechanisms in Oral Cancer Progression

  2019cites this paper
• Loss of heterozygosity and immunoexpression of PTEN in oral epithelial dysplasia and squamous cell carcinoma.

  2019cites this paper
• PTEN allelic loss is an important mechanism in the late stage of development of oral leucoplakia into oral squamous cell carcinoma

  2018cites this paper
• Association Between the PIK3CA Ile391Met Polymorphism and the Risk of Breast Cancer in an Iranian Population

  2018cites this paper
• Oridonin inhibits oral cancer growth and PI3K/Akt signaling pathway.

  2018cites this paper
• Estudo da via PI3k/AKT e da perda de Heterozigosidade do gene supressor tumoral Pten em lesões potencialmente malignas e Carcinoma epidermoide oral

  2017cites this paper
• Genetic profile of PTEN gene in Indian oral squamous cell carcinoma primary tumors

  2017cites this paper
• Contemporary Diagnostic Imaging of Oral Squamous Cell Carcinoma – A Review of Literature

  2017cites this paper
• Antitumor activity of the dual PI3K/MTOR inhibitor, PF-04691502, in combination with radiation in head and neck cancer.

  2017cites this paper
• Signature of genetic associations in oral cancer

  2017cites this paper
• Akt2 and p‐Akt overexpression in oral cancer cells is due to a reduced rate of protein degradation

  2017cites this paper
• Metabolic Reprogramming in Oral Squamous Cell Carcinoma

  2017cites this paper
• The molecular characterization of the progression of oral squamous cell carcinoma

  2016cites this paper
• Novel mutations of PIK3CA gene in head and neck squamous cell carcinoma

  2016cites this paper
• Mutational analysis of PI3K/AKT and RAS/RAF pathway activation in malignant salivary gland tumours with a new mutation of PIK3CA.

  2016cites this paper
• A comprehensive analysis of candidate gene signatures in oral squamous cell carcinoma.

  2016influential citation
• Downregulation of miR-221/222 by a microRNA sponge promotes apoptosis in oral squamous cell carcinoma cells through upregulation of PTEN

  2016cites this paper
• Genetic determinants in head and neck squamous cell carcinoma and their influence on global personalized medicine

  2016cites this paper
• Initial characterization of a Syap1 knock-out mouse and distribution of Syap1 in mouse brain and cultured motoneurons

  2016cites this paper
• Molecular characterization of oral squamous cell carcinoma using targeted next-generation sequencing.

  2015cites this paper
• Leveraging Next Generation Sequencing to Elucidate the Spectrum of Genetic Alterations Underlying Head and Neck Cancer and Identify Potential Therapeutic Targets

  2015cites this paper
• [Corrigendum] Identification of Akt1 as a potent therapeutic target for oral squamous cell carcinoma

  2015cites this paper
• Genetic alterations of the PIK3CA oncogene in human oral squamous cell carcinoma in an Indian population.

  2015cites this paper
• Genetic association between PIK3CA gene and oral squamous cell carcinoma: a case control study conducted in Chongqing, China.

  2015cites this paper
• The PI3K/Akt/mTOR axis in head and neck cancer: functions, aberrations, cross-talk, and therapies.

  2015cites this paper
• A Comprehensive Evaluation of Biomarkers Predictive of Response to PI3K Inhibitors and of Resistance Mechanisms in Head and Neck Squamous Cell Carcinoma

  2014cites this paper
• mTOR Co-Targeting in Cetuximab Resistance in Head and Neck Cancers Harboring PIK3CA and RAS Mutations

  2014cites this paper
• Combined mutational analysis of RAS, BRAF, PIK3CA, and TP53 genes in Taiwanese patients with oral squamous cell carcinoma.

  2014cites this paper
• EGFR, KRAS, BRAF, and PIK3CA characterization in squamous cell anal cancer.

  2014cites this paper
• Molecular diagnostic alterations in squamous cell carcinoma of the head and neck and potential diagnostic applications

  2014influential citation
• p62/SQSTM1 Accumulation in Squamous Cell Carcinoma of Head and Neck Predicts Sensitivity to Phosphatidylinositol 3-Kinase Pathway Inhibitors

  2014cites this paper
• Molecular mechanisms of HPV induced carcinogenesis in head and neck.

  2014cites this paper
• Anti-epidermal growth factor receptor therapy in head and neck squamous cell carcinoma: focus on potential molecular mechanisms of drug resistance.

  2013cites this paper
• Genetic deregulation of the PIK3CA oncogene in oral cancer.

  2013cites this paper
• Search for mutations in signaling pathways in head and neck squamous cell carcinoma.

  2013cites this paper
• The determinants of head and neck cancer: Unmasking the PI3K pathway mutations.

  2013cites this paper
• Frequent Mutation of the PI 3 K Pathway in Head and Neck Cancer Defi nes Predictive Biomarkers

  2013cites this paper
• Phosphorylated mammalian target of rapamycin is associated with an adverse outcome in oral squamous cell carcinoma.

  2013cites this paper
• Genome Stability Pathways in Head and Neck Cancers

  2013cites this paper
• Frequent mutation of the PI3K pathway in head and neck cancer defines predictive biomarkers.

  2013cites this paper
• Ras oncogenes in oral cancer: the past 20 years.

  2012cites this paper
• Arachidonic Acid Metabolism and Its Implication on Head and Neck Cancer

  2012influential citation
• PI3K‐independent AKT activation in cancers: A treasure trove for novel therapeutics

  2012influential citation